Article
Genomic Copy Number Variation Profiling of Pleural Effusion cfDNA via LP-WGS for Precision Diagnosis and Prognostic Stratification in Lung Adenocarcinoma-associated Malignant Pleural Effusion running title: cfDNA CNV for LUAD-MPE Diagnosis and Prognosis
2026-07-07
Abstract excerpt
<title>Abstract</title> <p> Background Lung adenocarcinoma (LUAD)-associated malignant pleural effusion (MPE) is an advanced disease hallmark with a median survival of 3–12 months. Current diagnostic strategies suffer from critical limitations: cytological examination has inadequate sensitivity, invasive biopsy is poorly tolerated by some patients, and traditional biomarkers such as carcinoembryonic antigen (CE...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- f128f80a-6c05-5dfb-8acd-20fc977067d0
- DOI
- 10.21203/rs.3.rs-10131380/v1
